Sugi Predict
/ Targets
/ OCIAD2
Top predicted compounds (top 20 by supporting neighbours, then confidence)
| Compound | Confidence | Supporting neighbours |
|---|
Clinical trials — most relevant to OCIAD2 by text similarity (a relevance ranking, not an exhaustive list)
| Trial | Phase | Status |
|---|
| Reducing the Risk of Drug-Induced QT Interval Lengthening in Women |
PHASE4 | COMPLETED |
| An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC Deficiency |
PHASE1/PHASE2 | RECRUITING |
| Study With Trabectedin in BRCA1 and BRCA2 Mutation Carrier and BRCAness Phenotype Ovarian Cancer |
PHASE2 | UNKNOWN |
| Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB) |
PHASE1/PHASE2 | RECRUITING |
| Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma |
PHASE2 | RECRUITING |
| Phase 1 Novel Live Attenuated Serotype 2 Oral Polio Vaccine Study in Inactivated Polio Vaccine (IPV) Primed Adults |
PHASE1 | COMPLETED |
| Choline Effects - Pre-symptomatic AD |
PHASE1 | COMPLETED |
| Genetics of Obsessive-Compulsive Disorder |
nan | COMPLETED |
| Discovery and Validation of Protein Structural Complexes in Circulating Biofluids As Novel Biomarkers for Early Diagnosis, Prognosis and Therapeutic Management of Patients Affected by Neurodegenerative Disorders |
nan | RECRUITING |
| Genetic Characterization of Parkinson's Disease |
nan | COMPLETED |
| Neurologic Injuries in Adults With Urea Cycle Disorders |
nan | COMPLETED |
| Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism |
nan | COMPLETED |
| Leveraging Artificial Intelligence and Multi-Omics Data to Predict Opioid Addiction |
nan | ACTIVE_NOT_RECRUITING |
| Prospective Genetic Study in Patients With Ovarian Insufficiency |
nan | UNKNOWN |
| Study of the Genetic Factors Involved in Autism and Related Disorders |
nan | RECRUITING |
| Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study |
nan | COMPLETED |
| Whole Genome Analysis for the Detection of Key Genes in the Polycystic Ovary Syndrome |
nan | UNKNOWN |
| Investigation of Copy Number Variations and Genetic Variants in POI |
nan | RECRUITING |
| Consortium On Risk for Early-onset Parkinson's Disease (CORE PD) |
nan | COMPLETED |
| Characterization of Epithelial Ovarian Cancer Patients in Terms of Homologous Recombination Phenotype |
nan | RECRUITING |
| Salivary Ap4A, SCCA, TROP2 in Oral Cancer Patients |
nan | UNKNOWN |
| A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration |
nan | RECRUITING |
| Clinical Utility of Early vs. Late Blood Biomarker Testing for Alzheimer's Disease |
nan | WITHDRAWN |
| Clinical Significance of Germline BRCA Mutations |
nan | ACTIVE_NOT_RECRUITING |
| Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer |
nan | COMPLETED |
| A Study on Risk Mutations of Vulnerability Genes of Schizophrenia |
nan | UNKNOWN |
| The Role of HE4 in the Follow-up of Advanced Ovarian, Fallopian Tube and Primary Peritoneal Cancer |
nan | UNKNOWN |
| New Strategies of Genetic Study of Patients With Oculocutaneous Albinism |
nan | COMPLETED |
| Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies |
nan | RECRUITING |
| Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk |
nan | COMPLETED |
Related proteins — ESM-2 sequence neighbours (a OCIAD2 binder may also engage these)